transcendmedical.com
Transcend Medical, Inc.Transcend is focused on the development of minimally invasive technologies for the treatment of glaucoma, the leading cause of adult irreversible blindness.
http://www.transcendmedical.com/
Transcend is focused on the development of minimally invasive technologies for the treatment of glaucoma, the leading cause of adult irreversible blindness.
http://www.transcendmedical.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
0.8 seconds
PERFECT PRIVACY, LLC
12808 Gra●●●●●●●●●kway West
Jack●●●●ille , FL, 32258
US
View this contact
PERFECT PRIVACY, LLC
12808 Gra●●●●●●●●●kway West
Jack●●●●ille , FL, 32258
US
View this contact
PERFECT PRIVACY, LLC
12808 Gra●●●●●●●●●kway West
Jack●●●●ille , FL, 32258
US
View this contact
BUY YOUR DOMAIN
17
YEARS
9
MONTHS
12
DAYS
NETWORK SOLUTIONS, LLC.
WHOIS : whois.networksolutions.com
REFERRED : http://networksolutions.com
PAGES IN
THIS WEBSITE
15
SSL
EXTERNAL LINKS
18
SITE IP
173.230.155.93
LOAD TIME
0.781 sec
SCORE
6.2
Transcend Medical, Inc. | transcendmedical.com Reviews
https://transcendmedical.com
Transcend is focused on the development of minimally invasive technologies for the treatment of glaucoma, the leading cause of adult irreversible blindness.
transcendmedical.com
Patient Resources
http://transcendmedical.com/patients/patient-resources
KeepYourSight provides the first clinically tested, FDA-cleared online visual field perimetry test for glaucoma. The Spaeth/Richman Contrast Sensitivity (SPARCS) test is designed to evaluate central and peripheral vision. The Internet-based test can be administered on a standard computer in an office setting or in the patient’s home. The American Glaucoma Society (AGS) supports glaucoma specialists and scientists through the advancement of education and research to promote excellence in the care of patie...
CyPass® Micro-Stent
http://transcendmedical.com/patients/cypass
A Potential New Treatment Option for Glaucoma. What is the CyPass. The CyPass Micro-Stent is a small device that is implanted just below the surface of the eye. It is designed to reduce intraocular pressure (IOP) in patients with primary open-angle glaucoma, which may reduce or eliminate the need for glaucoma medications. How does the CyPass. What are the potential benefits? May reduce or eliminate the need for glaucoma medications. Designed to provide continuous control of IOP. Transcend Medical, Inc.
Corporate News
http://transcendmedical.com/newsroom/corporate-news
Transcend Medical and Glaukos Corporation Settle Patent Litigation. Transcend Medical Submits Final Module of FDA Premarket Approval Application for the CyPass. Transcend Medical Announces Intent to File Premarket Approval Application with FDA for the CyPass. Transcend Medical and Volk Optical Launch the Transcend Vold Goniolens. Closing of $22 Million Series C Financing. Enrollment Complete in Landmark Glaucoma Study. 12-Month European Study Results of the CyPass. Closing of $51M Series B Financing.
Leadership
http://transcendmedical.com/about/leadership
Tsontcho [Sean] Ianchulev, MD MPH. Chief Medical Officer Vice President, Medical Affairs and Business Development. Ginger Clasby, MS. Vice President, Clinical and Regulatory Affairs. Vice President, Research and Development and Operations. General Manager, Europe, Middle East, and Africa (EMEA). Transcend Medical, Inc. Menlo Park, CA 94025. Phone No.: 650.223.6600. Fax: 650.223.6695.
CyPass® Micro-Stent
http://transcendmedical.com/physicians/cypass
A Potential New Treatment Option for Glaucoma. What is the CyPass. The CyPass Micro-Stent is a small device that is implanted just below the surface of the eye. It is designed to reduce intraocular pressure (IOP) in patients with primary open-angle glaucoma, which may reduce or eliminate the need for glaucoma medications. How does the CyPass. What are the potential benefits? May reduce or eliminate the need for glaucoma medications. Designed to provide continuous control of IOP. Transcend Medical, Inc.
TOTAL PAGES IN THIS WEBSITE
15
Sponsors | ICGS 2016
http://www.icgs2016.org/en/sponsors
Skip to main content. Exhibitors and other sponsors. International Congress on Glaucoma Surgery, in collaboration with the Oman Ophthalmic Society. Web Hosted by Oic S.r.l. International Congress Management.
ForSight Labs | Investors |
http://www.forsightlabs.com/investors.html
Canaan Equity VII, LP. HLM Venture Partners II, LP. Latterell Venture Partners III, LP. Technology Partners Fund VIII, LP.
ForSight Labs | Our Team |
http://www.forsightlabs.com/juan.html
Eugene de Juan, Jr., M.D. Renowned retinal surgeon, inventor, and entrepreneur Dr. Eugene de Juan, Jr., serves as Vice-Chairman of ForSight Labs, where he participates as an active inventor and advisor in early-stage ophthalmic device opportunities. Prior to moving to San Francisco, Dr. de Juan, Jr., was a professor of ophthalmology at the University of Southern California and chief executive officer of the Doheny Retina Institute, focusing on innovative techniques for treating blinding retinal d...Prior...
ForSight Labs | Our Team |
http://www.forsightlabs.com/gifford.html
Hanson S. Gifford, III. Chairman of the Board. President and CEO, The Foundry, Inc. Mr Gifford became the Chairman of ForSight Labs in March of 2007 after founding ForSight in 2005 with Dr. de Juan and The Foundry team.
ForSight Labs | Our Team |
http://www.forsightlabs.com/reich.html
Cary J. Reich, Ph.D. Dr Reich earned his B.S. degree in Chemistry from Harvey Mudd College, and his Ph.D. in Physical Organic Chemistry from Stanford. Cary is an inventor on over 25 US patents in ocular devices, biomaterials, surface coatings and surgical sealants.
ForSight Labs | Our Team |
http://www.forsightlabs.com/team.html
Our team members strive to make significant contributions to furthering medical technology. In collaboration with our partners, our extensive experience in ophthalmology, product-oriented research and development, business development, intellectual property, clinical and regulatory affairs, and general management provides the framework to form companies that succeed in delivering innovative solutions to the marketplace. Eugene de Juan, Jr., M.D. Founder and Vice Chairman. Cary Reich, Ph.D.
ForSight Labs | Join Us |
http://www.forsightlabs.com/join.html
Opportunities in Our Community. Currently, there are no open positions.
Latterell Venture Partners - Portfolio
http://www.lvpcapital.com/portfolio.html
Calistoga was recently acquired by Gilead Pharmaceuticals for total proceeds of up to $600 Million. The company was a cancer pharmaceutical company developing cancer treatments targeting PI3. Cellective was acquired by Medimmune for proceeds of up to $175 million. Cellective was developing several new pharmaceuticals treating B Cell related cancers and immune diseases. The technology is based on research by Founder Tom Tedder, Chairman of Immunology at Duke University. Neuraltus is a neuropharmaceutical ...
TOTAL LINKS TO THIS WEBSITE
18
Transcend Media Group - Our Work
Transcend Media | Interactive Customer Acquisition
On-Demand marketing services tied directly your to cost-per-converted customer acquisition targets. Monetize your website visitors with our highly effective, targeted digital ad solutions. Interested in becoming a partner?
TRANSCEND
クラウドワークスネットの副業サイト！２１世紀の新しいワークスタイル
Transcend Media Zambia | Home
Transcend Media aims to set itself apart from the conventional marketing and advertising companies in Zambia in two major ways. First, Transcend believes that the client is king and no task is too small or too big. Secondly we believe that any job can be done if you have the right tools. Continue Reading ». Media /Marketing consultant for ZANACO 2012. Client Service and Business Development – Coeur de Lion 2012. Filming of Documentary for UNICEF/ING visit - 2011. Marketing Director -Transcend Media 2009.
Transcend Medical, Inc.
A glaucoma micro-stent for cataract patients. Transcend Medical has developed micro-stent technology that is designed to be implanted at the time of cataract surgery in patients with primary open-angle glaucoma. About 20% of patients undergoing cataract surgery have a concurrent diagnosis of glaucoma in the US, this leads to over 700,000 patients per year who could benefit from combined therapy. Transcend Medical, Inc. Menlo Park, CA 94025. Phone No.: 650.223.6600. Fax: 650.223.6695.
Transcend Medical Billing
The Advantages of outsourcing. If you dont have the infrastructure in place to handle billing. Within your facility or practice, maybe it's time to outsource. Let’s face it, medical billing is confusing, complicated, and always. Changing. With Transcend Medical Billing Services, you have a. Dedicated team whose full-time job is to stay up to date on the. Latest requirements and do everything to get you paid. We troubleshoot. The rules and bureaucracy of insurance companies, and take the time. Issaquah WA...
TRANSCEND MEDICAL GROUP - Our Practice
Welcome to Transcend Medical Group! 160; Transcends focus is to provide personalized and state-of-the-art primary care for adult patients. Our attention is in the prevention and early detection of disease and for the delivery of quality health care for chronic illnesses. Dr. Nguyen has been in practicing Internal Medicine as a specialty since 2005. 183; Arlington Memorial Hospital. 183; Kindred Hospital. 183; Triumph Rehabilitation Hospital. Like us on Facebook!
Medi Spa Hudson, WI ( Wisconsin ) - Transcend Medi Spa LLC
Hudson, WI Medi Spa. Transcend Medi Spa LLC. Time is complex and beautiful, relentless and forgiving. Our medi spa services include:. Clinical services - If you are looking for Botox, Juvederm, Radiesse, Restylane, Perlane. Sclerotherapy - For spider vein removal. Skin tightening, stretch mark, and scar revision treatments. 1064 Long Pulse Laser - for port wine stains, warts, rosacea, hemangiomas, venus lake leg veins, spider veins, scars, striae, lentigos, angioms, skin tags. Facial and body waxing.
Learn Vedic Meditation | Course on How to Meditate
